小鹏汽车（9868.HK）系列点评十 2025Q4 首次季度盈利 物理 AI 加速突破 glmszqdatemark 2026 年 03 月 23 日 [Table_Author] 分析师：崔琰 分析师：完颜尚文 执业证书：S0590525110023 执业证书：S0590525110027 邮箱：cuiyan@glms.com.cn 邮箱：wanyanshangwen@glms.com.cn 事件：公司发布 2025Q4 财报：2025 年全年收入为 767.2 亿元，同比+87.7%， 其中：2025Q4 收入 222.5 亿元，同比/环比分别为+38.2%/+9.2%。2025Q4 汽 车业务毛利率为+13.0%，同比/环比分别为+3.0pts/-0.1pts。2025Q4 Non- GAAP 归母净利润为+5.1 亿元，首次实现季度盈利。 毛利率再创新高 首次实现季度盈利 营收端：2025Q4 实现单季营收入 222.5 亿元，同比/环比分别为+38.2%/+9.2%。 其中 2025Q4 汽车业务收入为 190.7 亿元，同比/环比分别为+30.0%/+5.6%， 主要由于交付量增加所致。2025Q ...

Investment Rating - The investment rating for Alibaba-W (09988.HK) is "Buy" (maintained) [1][29] Core Views - The company's FY26Q3 performance was below market expectations, with total revenue of RMB 284.84 billion, a year-on-year increase of 2%, which was lower than the consensus estimate of RMB 289.79 billion. Adjusted net profit was RMB 16.71 billion, a year-on-year decline of 67%, also below the expected RMB 29.58 billion. The main pressure on performance came from weak growth in the Chinese e-commerce business and significant investments in user experience, instant retail, and AI-related initiatives [12][19] - The cloud and AI segments continue to accelerate, with the Cloud Intelligence Group reporting revenue of RMB 43.28 billion, a year-on-year increase of 36%. The growth was driven by public cloud revenue and increased adoption of AI-related products. The company is advancing its "AI + Cloud" strategy across various segments, including high-performance networks and distributed storage [23][26] Summary by Sections Revenue Performance - The company's revenue performance was weak, with total revenue of RMB 284.84 billion in FY26Q3, a 2% year-on-year increase, falling short of market expectations. Adjusted net profit was RMB 16.71 billion, down 67% year-on-year [12][19] - The Chinese e-commerce group's revenue grew by 6% to RMB 159.35 billion, while customer management revenue (CMR) increased by only 1% to RMB 102.66 billion, reflecting a slowdown due to macroeconomic factors [16][19] E-commerce Business - The e-commerce main business showed stable performance, with instant retail maintaining high growth. Instant retail revenue grew by 56% to RMB 20.84 billion, making it the fastest-growing segment within the e-commerce group [20][21] - CMR growth has slowed, leading to temporary pressure on profitability, with adjusted EBITA margin at 22%, down 19 percentage points year-on-year [19][20] Cloud and AI Growth - The Cloud Intelligence Group continued its high growth trajectory, with revenue increasing by 36% to RMB 43.28 billion. The adjusted EBITA margin was 9%, driven by public cloud revenue growth and increased adoption of AI products [23][26] - The company is focusing on integrating AI with cloud services, enhancing capabilities in model training and inference, and has seen significant growth in AI-related product revenue [23][26] Earnings Forecast and Valuation - Due to the underperformance in FY26Q3, the forecast for Non-GAAP net profit for FY2026, FY2027, and FY2028 has been adjusted to RMB 78.88 billion, RMB 105.40 billion, and RMB 138.45 billion, respectively. The corresponding PE (Non-GAAP) ratios are projected to be 26.4, 19.7, and 15.0 times [26][29] - Despite the challenges, the cloud and AI segments remain the core growth drivers for the company, and it continues to be the largest online retail platform in the market, justifying the "Buy" rating [29]

Investment Rating - The investment rating for Geely Automobile is "Buy" (maintained) [1] Core Views - The Q4 performance of Geely Automobile is generally in line with expectations, with total revenue of 105.76 billion yuan, representing a year-on-year increase of 22.1% and a quarter-on-quarter increase of 18.6%. The net profit attributable to the parent company is approximately 3.74 billion yuan, showing a slight decline of 1.9% year-on-year and 2.0% quarter-on-quarter [8] - The company aims for a sales target of 3.45 million vehicles in 2026, which is a year-on-year increase of 14%. The new vehicle lineup includes models such as Zeekr 8x and Lynk & Co 07 [8] - The forecast for net profit attributable to the parent company for 2026 has been raised to 20.8 billion yuan, up from the previous estimate of 19.5 billion yuan, reflecting strong performance in high-end models and exports [8] Financial Summary - Total revenue projections for Geely Automobile are as follows: - 2024: 240.19 billion yuan - 2025: 345.23 billion yuan (up 43.73% year-on-year) - 2026: 412.87 billion yuan (up 19.59% year-on-year) - 2027: 476.83 billion yuan (up 15.49% year-on-year) - 2028: 518.64 billion yuan (up 8.77% year-on-year) [1] - Net profit attributable to the parent company is projected as follows: - 2024: 16.63 billion yuan - 2025: 16.85 billion yuan (up 1.32% year-on-year) - 2026: 20.80 billion yuan (up 23.44% year-on-year) - 2027: 24.44 billion yuan (up 17.51% year-on-year) - 2028: 28.19 billion yuan (up 15.33% year-on-year) [1] - The latest diluted EPS is projected to be: - 2024: 1.54 yuan - 2025: 1.56 yuan - 2026: 1.92 yuan - 2027: 2.26 yuan - 2028: 2.60 yuan [1]

23 Mar 2026 Earnings Summary CMB International Global Markets | Equity Research | Company Update | (YE 31 Dec) | FY23A | FY24A | FY25E | FY26E | FY27E | | --- | --- | --- | --- | --- | --- | | Revenue (RMB mn) | 20,278 | 21,910 | 24,571 | 29,752 | 34,792 | | YoY growth (%) | 30.5 | 8.0 | 12.1 | 21.1 | 16.9 | | Adjusted net profit (RMB mn) | 1,929.0 | 1,849.9 | 2,286.2 | 2,990.1 | 3,686.1 | | YoY growth (%) | 15.9 | (4.1) | 23.6 | 30.8 | 23.3 | | EPS (Adjusted) (RMB) | 0.61 | 0.58 | 0.71 | 0.92 | 1.13 | | Co ...

| [Table_EPS] 盈利预测与估值 | 2024A | 2025A | 2026E | 2027E | 2028E | | --- | --- | --- | --- | --- | --- | | 营业总收入（百万港元） | 30,258 | 27,521 | 27,145 | 26,966 | 26,808 | | 同比(%) | (5.71) | (9.05) | (1.36) | (0.66) | (0.59) | | 归母净利润（百万港元） | 3,377 | 3,925 | 4,161 | 4,267 | 4,373 | | 同比(%) | (23.75) | 16.23 | 6.01 | 2.55 | 2.49 | | EPS-最新摊薄（港元/股） | 0.55 | 0.64 | 0.68 | 0.69 | 0.71 | | P/E（现价&最新摊薄） | 9.33 | 8.03 | 7.57 | 7.39 | 7.21 | 证券研究报告·海外公司点评·环保 光大环境（00257.HK） 2025 年报点评：经营提效+减值收窄，国补回 款创新高，业绩&分红双超预期 买入（维持） [Tabl ...

Investment Rating - The investment rating for the company is "Buy" (maintained) [5] Core Insights - The company reported a strong performance in its annual report for 2025, with revenue of 29.6 billion, a year-on-year increase of 3.2%, and a net profit of 2.94 billion, down 2.6% year-on-year, but exceeding market expectations [1] - The company is focusing on multiple product categories for growth, particularly in running and training segments, while also exploring opportunities in niche markets [4] - The company maintained a healthy inventory turnover and cash flow, with operating cash flow of 4.85 billion, showcasing strong financial health [3] Revenue Analysis - The running category remains the largest contributor, accounting for 31% of total revenue with a growth rate of 10%, while new categories like outdoor and Honor Gold Standard have increased their revenue share to 8% [2] - The wholesale channel saw a revenue increase of 6.3%, driven by growth in professional channels, while e-commerce revenue grew by 5.3% [2] - Direct sales revenue declined by 3.3% due to store adjustments and a net reduction in the number of stores [2] Profitability and Forecast - The company expects to maintain strong performance in 2026, with projected revenues of 31.7 billion, a year-on-year increase of 7.1%, and net profit of 3 billion, reflecting a 2% growth [4] - The projected P/E ratios for 2026, 2027, and 2028 are 16.2, 14.3, and 12.9 respectively, indicating a favorable valuation outlook [4]

Investment Rating - The report maintains an "Outperform" rating for Giant Biogene with a target price of HKD 36.20, implying a potential upside of 17.9% from the current price of HKD 30.70 [2][3]. Core Insights - The company’s 2025 results were broadly in line with expectations, with total revenue of RMB 5.52 billion, a slight decline of 0.4% year-on-year. The attributable net profit was RMB 1.91 billion, down 7.1% year-on-year, but exceeded estimates by 2.1% [4][15]. - Revenue for 2026 is projected to grow to RMB 6.06 billion, representing a year-on-year increase of 9.8%, with attributable net profit expected to reach RMB 2.00 billion, reflecting a growth of 4.6% [3][14]. - The gross profit margin is expected to decline slightly from 80.3% in 2025 to 79.7% in 2026, while the net profit margin is projected to be 33.1% [10][14]. Financial Performance - The company achieved a gross margin of 80.3% in 2025, which was slightly below expectations, while the selling expense ratio was better than anticipated at 37.3% [4][15]. - Functional skincare products generated revenue of RMB 4.34 billion, growing 0.8% year-on-year, outperforming forecasts by 8.7%. In contrast, medical dressings saw a decline of 4.8% year-on-year to RMB 1.16 billion, falling short of projections by 21.6% [4][15][16]. Future Focus Areas - Key focus area 1 is the commercialization timeline and sales ramp-up of the medical aesthetics business, with two Class III medical device products approved and expected to launch in 2026. The company aims to leverage its network of approximately 4,700 hospitals and clinics [6][17]. - Key focus area 2 involves the sales performance of new products in 2026, particularly the Focus Series essence and the Zhixu Series. Management anticipates significant growth from these new launches, with specific sales targets set for the first year [8][18]. Balance Sheet and Dividends - As of the end of 2025, the company reported cash and cash equivalents of RMB 6.31 billion, a 56.5% increase year-on-year, with no interest-bearing debt. The total dividends declared for 2025 were RMB 1.29 billion, representing a payout ratio of approximately 67% [19].

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The company has achieved operational efficiency improvements and a reduction in impairment losses, with national subsidy collections reaching a record high, leading to performance and dividend results that exceeded expectations [1] - The company’s revenue for 2025 is projected at 27,521 million HKD, a decrease of 9.05% year-on-year, while the net profit attributable to shareholders is expected to rise by 16.23% to 3,925 million HKD [1] - The report highlights a significant increase in free cash flow and a dividend payout ratio increase to 42.3%, indicating strong potential for future dividends [1] Financial Summary - Revenue and Profit Forecasts: - Total revenue for 2024 is projected at 30,258 million HKD, decreasing to 27,521 million HKD in 2025, and further declining to 27,145 million HKD in 2026 [1] - Net profit attributable to shareholders is expected to grow from 3,377 million HKD in 2024 to 3,925 million HKD in 2025, and further to 4,161 million HKD in 2026 [1] - Earnings Per Share (EPS) is forecasted to increase from 0.55 HKD in 2024 to 0.64 HKD in 2025, reaching 0.68 HKD in 2026 [1] - Price-to-Earnings (P/E) ratio is projected to decrease from 9.33 in 2024 to 8.03 in 2025, and further down to 7.57 in 2026 [1]

Investment Rating - The investment rating for the company is "Buy" and is maintained [10] Core Insights - The company is expected to achieve revenue of 14.256 billion HKD and adjusted net profit of 1.530 billion HKD in 2025, representing a year-on-year increase of 21% and 1% respectively [2][7] - The company plans to distribute a dividend of 0.4 HKD per share for the year 2025, resulting in a dividend payout ratio of 234.4% [2][7] - The HNB (Heat-not-Burn) and vaping segments are performing positively, with HNB revenue expected to grow significantly due to new product launches in key markets [11] Revenue Summary - For 2025, the company anticipates a total revenue of 14.256 billion HKD, with a breakdown of 8.243 billion HKD in H2 and 4.046 billion HKD in Q4, showing year-on-year growth rates of 22% and 16% respectively [2][7] - The TOB (Tobacco Operating Business) is projected to contribute 80% of total revenue, with a 22% increase in revenue, while the TOC (Tobacco Operating Company) is expected to grow by 18% [11] Profitability Summary - The gross margin is expected to decline by 3.3 percentage points to 34.1% due to changes in product mix, with increased costs in stock-based compensation and legal services impacting profitability [11] - The company is projected to achieve adjusted net profits of 1.158 billion HKD, 2.020 billion HKD, and 2.770 billion HKD for the years 2026 to 2028, with corresponding PE ratios of 31, 24, and 18 [11] Long-term Outlook - The long-term outlook for HNB and vaping products is positive, with expected compound annual growth rates of 11.5% from 2025 to 2030 [11] - The company is also exploring new business opportunities in medical vaping and other specialized applications, with FDA certification for its manufacturing facility in the U.S. [11]

Investment Rating - The investment rating for the company is "Buy" and is maintained [9] Core Insights - The company reported a revenue of HKD 27.521 billion for 2025, a decrease of 9% year-on-year, while the net profit attributable to shareholders increased by 16% to HKD 3.925 billion. The annual dividend per share is set at HKD 0.27, up from HKD 0.23 in 2024 [2][6] - The operational business showed stable growth, with a 3% increase in the amount of municipal solid waste processed and a 5% increase in electricity generated [2] - The company plans to maintain a dividend payout of HKD 0.27 per share, with a payout ratio increasing by 0.5 percentage points to 42.3%, indicating potential for further dividend increases in the future [2] Summary by Sections Revenue and Profitability - The total revenue for 2025 was HKD 27.521 billion, with operational service revenue contributing HKD 19.833 billion (up 2% year-on-year) and construction service revenue at HKD 2.722 billion (down 53%) [10] - The company processed 53.704 million tons of municipal solid waste in 2025, reflecting a 3% year-on-year growth, and generated 1,785.7 million megawatt-hours of electricity, a 5% increase [10] Financial Performance - Asset impairments decreased, and financial expenses were reduced by HKD 6.1 billion, primarily due to debt restructuring and loan repayments, with total outstanding loans decreasing by HKD 3.1 billion to HKD 88.5 billion [10] - The company’s cash flow is expected to improve, with anticipated government subsidies contributing to a positive cash flow situation [10] Future Outlook - The trend of collaborative treatment of multiple solid wastes is expected to enhance performance, with waste incineration projects becoming core assets [10] - The company plans to issue up to 800 million shares, not exceeding 11.52% of the post-issue share capital, with projected net profits for 2026-2028 estimated at HKD 4.2 billion, HKD 4.5 billion, and HKD 4.7 billion respectively [10]